In fiscal year 2023, GlaxoSmithKline Pharmaceuticals Limited in India reported nearly eight billion Indian rupees as earnings before interest, tax, depreciation and amortization. This was an increase compared to the previous fiscal year's 7.5 billion rupees worth EBITDA. In financial year 2023, GSK ranked as the leading brand in the anti-infectives and dermatology segment.
EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2023
(in billion Indian rupees)
Characteristic
EBITDA in billion Indian rupees
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
GlaxoSmithKline. (June 17, 2023). EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2023 (in billion Indian rupees) [Graph]. In Statista. Retrieved August 25, 2024, from https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. "EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2023 (in billion Indian rupees)." Chart. June 17, 2023. Statista. Accessed August 25, 2024. https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. (2023). EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2023 (in billion Indian rupees). Statista. Statista Inc.. Accessed: August 25, 2024. https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. "Ebitda of Gsk Pharmaceuticals Limited in India from Financial Year 2015 to 2023 (in Billion Indian Rupees)." Statista, Statista Inc., 17 Jun 2023, https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline, EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2023 (in billion Indian rupees) Statista, https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/ (last visited August 25, 2024)
EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2023 (in billion Indian rupees) [Graph], GlaxoSmithKline, June 17, 2023. [Online]. Available: https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/